Skip to main content
Equibles

NATIONAL BANK OF CANADA /FI/

Bank

Position in GPCR — Structure Therapeutics Inc.

CIK 926171 MONTREAL, A8
Back to GPCR Full portfolio

Position in GPCR

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$11,581,986
-$3,138,294 QoQ
Shares Held
215,800
-29.3% QoQ
Ownership
0.303%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#39
of 190 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GPCR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NATIONAL BANK OF CANADA /FI/ holds $632,429,861 across 151 Biotechnology names. GPCR ranks #7 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 1,096,025 $205,263,562
2 MRNA
Moderna, Inc.
 1,424,802 $99,778,883
3 ROIV
Roivant Sciences Ltd.
 2,773,874 $98,167,400
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 172,898 $85,883,622
5 REGN
Regeneron Pharmaceuticals, Inc.
 125,812 $78,448,813
6 ALNY
Alnylam Pharmaceuticals, Inc.
 52,467 $15,794,140
7 GPCR
Structure Therapeutics Inc.
This page 		215,800 $11,581,986
8 ABCL
AbCellera Biologics Inc.
 1,233,014 $9,679,159

All Filings in GPCR

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,581,986 215,800
2026-03-31 $14,720,280 305,400
2025-12-31 $18,458,570 265,400
2025-09-30 $4,032,000 144,000
2025-06-30 $4,148 200
2025-03-31 $51,185 2,957
2024-12-31 $5,179 191
2024-09-30 $9,304 212